OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 16 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,623,000 | -0.2% | 6,000,000 | 0.0% | 0.02% | -4.0% |
| Q2 2016 | $1,627,000 | -32.8% | 6,000,000 | 0.0% | 0.02% | -63.8% |
| Q1 2016 | $2,422,000 | -30.8% | 6,000,000 | 0.0% | 0.07% | -8.0% |
| Q4 2015 | $3,498,000 | -16.4% | 6,000,000 | 0.0% | 0.08% | -24.2% |
| Q3 2015 | $4,186,000 | -61.6% | 6,000,000 | -47.8% | 0.10% | -59.9% |
| Q2 2015 | $10,894,000 | -31.3% | 11,500,000 | -16.4% | 0.25% | -21.8% |
| Q1 2015 | $15,848,000 | +13.8% | 13,764,000 | 0.0% | 0.32% | +16.6% |
| Q4 2014 | $13,930,000 | – | 13,764,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $5,025,000 | 0.78% |
| GLG LLC | 4,960,000 | $2,480,000 | 0.15% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 7,500,000 | $3,000,000,000 | 0.05% |